WU vs IVZ
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 18, 2026
WU
61.1
AI Score
VS
IVZ Wins
IVZ
65.5
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | WU | IVZ | Winner |
|---|---|---|---|
| Revenue | 2.00B | 3.57B | IVZ |
| Net Income | 141.40M | 558.00M | IVZ |
| Net Margin | 7.1% | 15.6% | IVZ |
| Operating Income | 255.10M | 697.40M | IVZ |
| ROE | 15.5% | 4.5% | WU |
| ROA | 1.8% | 2.0% | IVZ |
| Total Assets | 7.97B | 27.47B | IVZ |
| Cash | 919.80M | 915.40M | WU |
| Debt/Equity | 2.74 | 0.13 | IVZ |
| Free Cash Flow | 197.20M | 902.10M | IVZ |
Relative Price Performance (Last 90 Days)
WU 1M: +5.1%
· 3M: -22.4%
IVZ 1M: -8.5%
· 3M: -6.8%
Current Technical Phase
WU
NeutralHold
Mixed signals - no dominant trend phase, RSI 51
IVZ
MarkdownSell / avoid
Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 36
Fundamentals Snapshot
| Metric | WU | IVZ |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 4.2 | 8.6 |
| Trailing P/E | 5.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.2% |
| Gross Margin | 0.4% | 0.3% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 1.23 | -0.68 |
| Dividend Yield | 0.15% | 0.03% |
Frequently Asked Questions
Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.